Georgia · J7329

Hyaluronan Or Derivative, Trivisc, For Intra-Articular Injection, 1 Mg in Georgia

Georgia Medicare Avg
$7.06
0% above national avg
National Medicare Avg
$7.04
All states combined
Billed Charge (GA)
$22.96
What providers submit
Est. Commercial (GA)
$20.39
National avg: $20.00
Est. Cash / Self-Pay (GA)
$13.11
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

144.7K
Services in GA
175
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Georgia

Provider Medicare Services
Manrique, Richard MD $7.33 8.3K
Bilotta, Jessica MD $7.20 7.1K
Day, John M.D. $7.16 5.5K

Georgia Pricing in Context

In Georgia, CPT code J7329 (Hyaluronan Or Derivative, Trivisc, For Intra-Articular Injection, 1 Mg) carries an average Medicare payment of $7.06 — 0% above the national benchmark of $7.04. 175 providers across the state submitted claims for this procedure in 2023, performing 144.7K total services. Individual payments in GA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Georgia is $22.96, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Georgia sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Drugs (Administered) procedures, the estimated commercial insurance price in Georgia lands near $20.39, with self-pay cash prices typically around $13.11. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Hyaluronan Or Derivative, Trivisc, For Intra-Articular Injection, 1 Mg cost in Georgia?

The average Medicare payment for Hyaluronan Or Derivative, Trivisc, For Intra-Articular Injection, 1 Mg in Georgia is $7.06, which is 0% above the national average of $7.04. Providers in GA typically bill $22.96 for this procedure.

What does Hyaluronan Or Derivative, Trivisc, For Intra-Articular Injection, 1 Mg cost with insurance in Georgia?

With commercial insurance in Georgia, Hyaluronan Or Derivative, Trivisc, For Intra-Articular Injection, 1 Mg costs an estimated $20.39. Without insurance, the estimated cash price is $13.11. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Hyaluronan Or Derivative, Trivisc, For Intra-Articular Injection, 1 Mg in Georgia?

175 providers in Georgia billed Medicare for Hyaluronan Or Derivative, Trivisc, For Intra-Articular Injection, 1 Mg in 2023, performing 144.7K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Hyaluronan Or Derivative, Trivisc, For Intra-Articular Injection, 1 Mg cheaper in Georgia than the national average?

No — Hyaluronan Or Derivative, Trivisc, For Intra-Articular Injection, 1 Mg costs 0% above the national average in Georgia. The state average Medicare payment is $7.06 compared to $7.04 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial